0001209191-15-085435.txt : 20151215
0001209191-15-085435.hdr.sgml : 20151215
20151215180655
ACCESSION NUMBER: 0001209191-15-085435
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151214
FILED AS OF DATE: 20151215
DATE AS OF CHANGE: 20151215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGowan Pauline
CENTRAL INDEX KEY: 0001594782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 151289518
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-14
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001594782
McGowan Pauline
C/O CONCERT PHARMACEUTICALS, INC.
99 HAYDEN AVENUE, SUITE 500
LEXINGTON
MA
02421
0
1
0
0
VP, Finance
Common Stock
2015-12-14
4
M
0
498
3.50
A
498
D
Common Stock
2015-12-14
4
S
0
498
20.0735
D
0
D
Employee Stock Option (right to buy)
3.50
2015-12-14
4
M
0
498
0.00
D
2021-12-12
Common Stock
498
0
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $19.65 to $20.24 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price
This option is fully vested.
/s/ Pauline McGowan
2015-12-15